Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Si-xuan Qian
Clinical Efficacy and Safety of Imatinib in the Management of Ph+ Chronic Myeloid or Acute Lymphoblastic Leukemia in Chinese Patients
OncoTargets and Therapy
Oncology
Pharmacology
Related publications
Long-Term Safety and Efficacy of Dasatinib in the Treatment of Chronic-Phase Chronic Myeloid Leukemia Patients Resistant or Intolerant to Imatinib
Blood and Lymphatic Cancer: Targets and Therapy
Long-Term Efficacy and Safety of Dasatinib in Patients With Chronic Myeloid Leukemia in Accelerated Phase Who Are Resistant to or Intolerant of Imatinib
Blood Cancer Journal
Oncology
Hematology
Efficacy and Safety of Imatinib Mesylate (Glivec™) in Combination With Interferon-Α (IFN-α) in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL)
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
DNMT3A Mutations and Clinical Features in Chinese Patients With Acute Myeloid Leukemia
Cancer Cell International
Cancer Research
Oncology
Genetics
Therapeutic Drug Monitoring of Imatinib for Chronic Myeloid Leukemia Patients
Dasatinib in the Treatment of Imatinib Refractory Chronic Myeloid Leukemia
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Imatinib and Plasmacytoid Dendritic Cell Function in Patients With Chronic Myeloid Leukemia
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Gene Expression Signature of Primary Imatinib-Resistant Chronic Myeloid Leukemia Patients
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Micro-Rna Response to Imatinib Mesylate in Patients With Chronic Myeloid Leukemia
Haematologica
Hematology
